AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Novel generations of influenza vaccines reviewed.
2003 JUL 2 - (NewsRx.com & NewsRx.net) -- A review of the new generations of influenza vaccines has been published in the journal Vaccine.
According to recent research from the United States, "Several strategies are being pursued to increase the quality and quantity of influenza vaccines that are used on an annual basis including increasing the immunogenicity of currently licensed inactivated vaccines, delivery of inactive vaccines directly to the nasal mucosa, the use of cell lines for virus production and the use of live, attenuated vaccines."
"In addition, modern molecular biological techniques are being used to create and evaluate new vaccine approaches," said George Kemble at MedImmune Vaccines and Harry Greenberg at Stanford University. "This report will briefly review these ...
- USA: MEDIMMUNE VACCINES AWARDED CONTRACT FOR INFLUENZA VACCINE.
- Newspaper article from: IPR Strategic Business Information Database May 27, 2009 700+ words
According to DOD: MedImmune Vaccines, Inc., Gaithersburg, Md., is being awarded a maximum $32,293,397 firm fixed price, sole source contract for influenza...
- MedImmune Vaccines, Gaithersburg, MD, June 21 (CBER).(BLOOD/BIOLOGICAL DEVICES)
- Newspaper article from: Warning Letter Bulletin July 1, 2005 700+ words
CBER's Office of Compliance and Biologics Quality (OCBQ reviewed the DTC Vaccine Assessment Tool Flyer for F1uMist (Influenza Virus Vaccine Live, Intranasal) and found that the flyer misleading because it failed to reveal risks associated with the vaccine. The flyer only stated that there are risks
- A FluMist campaign targeting physicians and pharmacists is under way from...
- Magazine article from: Medical Marketing & Media September 1, 2003 700+ words
A FluMist campaign targeting physicians and pharmacists is under way from Medlmmune Vaccines and Wyeth. A national DTC program, scheduled to launch this month, is being developed by Saatchi & Saatchi, New York. The budget for the first season is estimated at $50 million, of which half will be
- Influenza vaccines from two facilities have similar safety and efficacy...
- Newspaper article from: Vaccine Weekly April 9, 2003 700+ words
...safety and immunogenicity profiles of live-attenuated influenza vaccines blended and filled at two manufacturing facilities were...Melbourne, the Murdoch Children's Research Institute, and MedImmune Vaccines. "Two doses of CAIV-T were given 4-6 weeks apart...
- FDA Finalizes Guidances for Pandemic and Seasonal Influenza Vaccines.
- Press release article from: M2 Presswire June 1, 2007 700+ words
...Guidances for Pandemic and Seasonal Influenza Vaccines (C)1994-2007 M2 COMMUNICATIONS...the supply of safe and effective influenza vaccines for both seasonal and pandemic use...commitment to help increase the supply of influenza vaccines and support the development of new...
- Influenza Vaccines and Antivirals.
- Press release article from: M2 Presswire August 26, 2009 700+ words
...August 2009-Bharat Book Bureau: Influenza Vaccines and Antivirals(C)1994-2009...report on "Commercial Insight: Influenza Vaccines and Antivirals - The pandemics long...different scenarios Commercial Insight: Influenza Vaccines and Antivirals - The pandemics long...
- Aventis and Crucell Announce Strategic Agreement to Develop and Commercialize...
- Press release article from: PR Newswire January 7, 2004 700+ words
...covers both pandemic and epidemic influenza vaccines, which up to now have been part...manufacture and market cell-based influenza vaccines using Crucell's unique PER.C6...in the production and marketing of influenza vaccines. In 2002, Aventis Pasteur's consolidated...
- Inovio Biomedical and NIH Vaccine Research Center Sign Research Collaboration...
- Press release article from: Business Wire August 10, 2009 700+ words
...Research Center (VRC) to develop influenza vaccines. Under the agreement, the VRC and...technologies to develop universal influenza vaccines as well as rapidly advance development...technology is the inability to create influenza vaccines that can protect against new, unmatched...
Source: HighBeam Research, Novel generations of influenza vaccines reviewed.